tiprankstipranks
Repligen price target raised to $225 from $175 at Craig-Hallum
PremiumThe FlyRepligen price target raised to $225 from $175 at Craig-Hallum
2M ago
Repligen price target raised to $207 from $165 at Stifel
PremiumThe Fly
Repligen price target raised to $207 from $165 at Stifel
2M ago
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
2M ago
Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
PremiumPress ReleasesRepligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
4M ago
Repligen announces data for odronextamab in R/R FL from Phase 2 trial
PremiumThe Fly
Repligen announces data for odronextamab in R/R FL from Phase 2 trial
4M ago
Repligen sees year-end cash, cash equivalents $717M-$727M
PremiumThe Fly
Repligen sees year-end cash, cash equivalents $717M-$727M
4M ago
Repligen announces publication of 2022 sustainability report
PremiumThe FlyRepligen announces publication of 2022 sustainability report
5M ago
Repligen Announces Publication of the Company’s 2022 Sustainability Report
PremiumPress Releases
Repligen Announces Publication of the Company’s 2022 Sustainability Report
5M ago
Repligen price target lowered to $150 from $165 at Deutsche Bank
PremiumThe Fly
Repligen price target lowered to $150 from $165 at Deutsche Bank
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100